Neck and Shoulder arthritis two years after stem cell therapy by Harry Adelson, N.D.
Steve describes his outcome two years after stem cell therapy for his arthritic neck and shoulder by Dr Harry Adelson http://www.docereclinics.com.
By: Harry Adelson, N.D.
View original post here:
Neck and Shoulder arthritis two years after stem cell therapy by Harry Adelson, N.D. - Video
A new study by a Swedish institution suggests that infertility cannot be successfully treated with stem cells.
"Ever since 2004, the studies on stem cell research and infertility have been surrounded by hype," Xinhua news agency quoted Kui Liu, a researcher at the Department of Chemistry and Molecular Biology at the University of Gothenburg as statinf in the study.
"There has been a great amount of media interest in this, and the message has been that the treatment of infertility with stem cells is about to happen. However, many researchers, including my research group, have tried to replicate these studies and not succeeded."
According to the old theory that the Swedish researchers are questioning, infertile women, such as those who have entered menopause, could be given new eggs. However, staff at Liu's laboratory carried out experiments on mice that showed that the only eggs female mice have are the ones they have had since birth.
"This shows not only that the use of stem cell research in the clinical treatment of childlessness is unrealistic but also that clinics should focus on using the eggs that women have had since birth in treating infertility," says Professor Liu.
These new research studies have been published in the journal Proceedings of the National Academy of Sciences (PNAS).
Go here to see the original:
Doubt over stem-cell based infertility treatment
Whether or not infertility can be treated with stem cells has been a matter of debate for many years.
The classical theory is based on the idea that the eggs a woman has are the ones she has had from birth, but there are researchers who claim that stem cell research could lead to the creation of new eggs. If so, this would mean that infertile women, such as those who have entered the menopause, could be given new eggs.
New studies done by researchers at the University of Gothenburg and Karolinska Institute now show that the dream of successfully treating infertility with stem cells will probably not be realized. These new research studies have been published in the journal Proceedings of the National Academy of Sciences (PNAS).
"Ever since 2004, the studies on stem cell research and infertility have been surrounded by hype. There has been a great amount of media interest in this, and the message has been that the treatment of infertility with stem cells is about to happen. However, many researchers, including my research group, have tried to replicate these studies and not succeeded. This creates uncertainty about whether it is at all possible to create new eggs with the help of stem cells," says Kui Liu, a researcher at the Department of Chemistry and Molecular Biology at the University of Gothenburg.
Together with Outi Hovatta's research group at Karolinska Institute and Jan-ke Gustafsson's research team at the University of Houston in the United States, staff at Professor Liu's laboratory have carried out experiments on mice showing that the only eggs female mice have are the ones they have from birth.
"This shows not only that the use of stem cell research in the clinical treatment of childlessness is unrealistic but also that clinics should focus on using the eggs that women have had since birth in treating infertility," says Professor Kui Liu.
Dr. Kui Liu is a Professor at the Department of Chemistry and Molecular Biology at the University of Gothenburg. His group specialises in the study of the genetic and epigenetic regulation of female germ cell development. Research in recent years has covered both preclinical basic research and the transfer of the results generated from studies of mouse models to clinically applicable techniques for treating female infertility.
Story Source:
The above story is based on materials provided by University of Gothenburg. The original article was written by Carina Eliasson. Note: Materials may be edited for content and length.
Read more:
Researchers question treatment of infertility with stem cells
Freeport, Grand Bahama (PRWEB) February 04, 2015
In just a few short months since Okyanos opened its doors, remarkable results are becoming a daily reality. In light of these mounting successes, Okyanos, the leader in cell therapy, has augmented its adult stem cell therapy for severe heart disease and expanded their offerings to include treatments for patients with other chronic unmet needs. Now, patients like Patsy and Dylan are experiencing the tangible benefits that Okyanos cell therapy provides.
Patsy, 72 years old, lived a normal life until 2012 when a diagnosis of congestive heart failure (CHF) put a halt to her active lifestyle. Patsys health quickly deteriorated. Despite open heart surgery, a pacemaker and medications, all were insufficient to arrest her physical decline. Faced with a heart transplant as her next option and fearful of the idea, Patsy began searching for another alternative.
I was looking at going to Mexico, and my cardiologist was talking to me about being a part of a clinical trial where they inject two different kinds of drugs into the heart, but I was hesitant about that idea and worried I would get the placebo. A friend knew I had a heart problem, and she recommended Okyanos.
Patsys arrival at Okyanos quickly allayed any apprehension as she said, I couldnt ask to be treated any better than if they were my own sisters or brothers. It was truly amazing. You just dont get that kind of care in regular hospitals.
After just a few short months since her mid-October (2014) treatment with Okyanos cell therapy, Patsy is noticing improvements. Im doing better. I can already tell the difference. Im getting up the stairs more easily. Im doing the laundry again. I have more energy, and when you have more energy and you feel better, your point of view on life is betterit really makes a big difference.
Dylan is another success. At 16, Dylan had dreamt of a career playing tennis but began experiencing extreme pain with his hips locking up, causing him to fall to the ground. He was diagnosed with a rare condition that causes abnormal growth of tissue lining the joints that can later break off and damage cartilage. After 2 surgeries to clean out his hips, constant pain and an inability to walk without a limp, run or bend over, the condition worsened. After speaking with doctors, it was clear that continuation of regular surgeries would further deteriorate Dylans hips. Determined to see her son walk normally, Dylans mother discovered Okyanos and both decided to move forward with cell therapy.
Dylan underwent cell therapy wherein stem cells were separated from his own fat tissue for direct injections into the hip as well as delivery by IV to address underlying causes of ischemia, inflammation and abnormal immune response. Ten days later, Dylan was pain-free and able to walk normally, run and bend over.
Im pinching myself. Its amazing. No, its miraculous! says Elena about her sons recovery. If Dylan had not had the cell therapy, we would have kept doing other treatments and crossed our fingers. At 20 years old, his future would have been hip replacement surgery and a lifetime of problems walking, painful movement and an inability to bend down.
Stem cell therapy is a relatively simple and minimally-invasive same-day procedurea stark contrast from open heart surgery or hip surgeryyet offers patients the hope of a more normal life. Patients like Patsy concur, Its going to give people hope. And give them a life. You get to a point with a body where you push and push and run out of energy. Thats not really life to me. I think stem cell therapy can give back life.
Read more from the original source:
Okyanos Cell Therapy Success Brings Hope for a Normal Life
Nicholasville, KY (PRWEB) February 04, 2015
Rescued when he was only 4 weeks old, Nakiia, a 15-year-old Panther, has been living in severe pain after a jumping incident. Jan Hall, Nakiias owner has dedicated her life to rescuing animals. Nakiia, the namesake of her rescue foundation The Nakiia Foundation is the love of her life. Witnessing this fabulous animal in such pain was too much for Jan to bear. The Doctors treating Nakiia decided to undertake a revolutionary medical procedure, which centers on regenerative medicine.
Newman Veterinary Center in DeLand Florida performed MediVets Adipose (fat)-derived stem cell therapy. The male Florida panther underwent this procedure, more commonly performed on domestic animal such as dogs, cats and horses. The procedure is an effort to ease the pain from severe arthritis in his joints. This was a last stage effort for the panther that can no longer continue to live in such pain.
Though stem cell treatments have been performed in exotic animals before, it is still a rare and exciting undertaking. Utilizing MediVet Biologics procedure, Dr. Ted Oliver was able to ensure the process will produce the best possible results. MediVets procedure is completed in one day and in-clinic.
Stem Cell treatments in the past have often been controversial when embryonic cells where involved, with adipose or fat tissue Nakiias own adult stem cells could be easily concentrated and activated with minimal risk. Until recently Veterinarians only had the option of utilizing outside labs for processing of autologous cells, with the one step surgical treatment available from MediVet Biologics, Veterinarians all around the country can eliminate the costs and variability in shipping by utilizing an onsite simple procedure.
During the procedure, Dr. Oliver removed about four tablespoons of belly fat from the panther. The fat was then processed in-clinic by a trained technician. The cells are incubated, isolated and activated by a patented process. Dr. Oliver carefully re-administered the cells directly back into Nakiia. Nakiias excess cells will be stored for future use eliminating the need to surgically re-harvest additional tissue.
MediVets primary mission and goal is to help all animals live a pain free life. In regenerative medicine and biologic intervention age is not a disease rather a challenge that presents us many opportunities to develop cutting edge treatments to combat issues related to the aging process. Our partnerships with progressive Veterinarians such as Newman Veterinary Centers allow us to extend affordable cutting edge treatments to animals who otherwise potentially have limited treatments available. We look forward to following Nakiias progress." - Jeremy Delk, CEO of MediVet Biologics.
Newman Veterinary Center was honored to be a part of Nakiias stem cell procedure. The excitement that this 146-lb. cat brought to our clinic was unparalleled. We have very high hopes that Nakiia will be feeling much better very soon. - Erica Kent Director of Operations at Newman Veterinary Centers.
Nakiias story will air on Wednesday, February 4th on CBS WKMG (local 6) with Mike Holfeld, Investigative Reporter.
About MediVet Biologics MediVet Biologics is the Worlds leading provider of Veterinary regenerative medicine. The central Kentucky based company was founded in 2009 and quickly gained favor in the Veterinary industry with the advent of in-clinic adipose derived stem cell and platelet rich plasma treatments. Since gaining wide appeal in the small and large veterinary market MediVet Biologics has developed a strong biologic pipeline that includes, among other cutting edge treatment options, patient specific immunotherapy services.
Here is the original post:
Florida Panther Receives Cutting Edge Stem Cell Procedure from MediVet Biologics
Gordie Howe is making a remarkable recovery from a stroke that nearly led to him being placed in hospice care last fall.
The hockey great has gained 20 pounds and is doing fantastic after undergoing stem-cell treatment in Mexico in early December, one of his sons told NHL Live. Howe continues to recover at the Lubbock, Texas, home of his daughter.
Hes doing very, very well, said Dr. Murray Howe, director of sports medicine imaging of Toledo Hospital. He has good days and bad days like anybody whos 86, but overall hes heading in the right direction really every day, a little bit better. He had his stem cell treatment Dec. 8 and really since that time hes just been doing fantastic.
He loves to be busy. If you want to torture him just make him sit down and watch television. He is just about doing stuff. Hes in great spirits. He has an excellent quality of life. Hes doing all the things that he wants to do now other than fishing, only because we havent taken him fishing since his treatment, but hes looking forward to doing that.
Howe was unable to stand, walk or feed himself after suffering the stroke in late October. He was losing weight because he wasnt able to sustain himself in terms of eating, his son said. He essentially got to the point where he was bedridden and it was just no quality of life there.
Although it was feared that he had suffered another stroke in early December, he was suffering from dehydration, but his family was told to consider hospice care. At around the same time, a San Diego biopharmaceutical company reached out to offer treatment at no charge. According to Howes son, the results were instant. From NHL.coms Jon Lane:
Gordie Howe had the treatment Dec. 8 in Tijuana at a Mexican stem cell company called Novastem thats licensed the use of Stemedicas cells for clinical trials approved by the Mexican government. Neural stem cells were injected into the spinal canal on Day 1 and mesenchymal stem cells by intravenous infusion on Day 2, according to a release sent by the Howe family in mid-December.
They said that we might see some changes in my father within 24 hours and I just didnt believe it, Dr. Howe said.
Eight hours later, Gordie Howe began talking. He then demanded to walk to the bathroom.
I said Ill get the urinal because you cant walk and he says, Well the [heck] I cant walk, Dr. Howe said. We actually sat up and put his feet down on the side of bed and I was absolutely stunned. Id never seen anything like it in 28 years of doing medicine.
More here:
Gordie Howe recovering from stroke after stem-cell transplant
Scottsdale, AZ (PRWEB) February 03, 2015
On February 9th, a new stem cell treatment facility will open its doors in Scottsdale. The Lung Institute provides patients with an effective way to treat their lung diseases, such as COPD and pulmonary fibrosis. With locations in Tampa and Nashville, the Lung Institute has made positive strides in each city and will bring the same amount of involvement to the Scottsdale community.
Headed by Dr. Burton Feinerman, a world-renowned physician and expert in the field of regenerative medicine, the Lung Institute has performed hundreds of minimally invasive, outpatient stem cell therapies for a variety of debilitating lung diseases. With these treatments, the Lung Institute successfully offers world-class care to their patients who travel from around the world to visit their clinics.
The addition of this facility means more medical, sales and administrative jobs for Scottsdale residents. Since most patients travel to receive treatment, local businesses will benefit from the increase in visitors. Patient coordinators at the Lung Institute actively promote all that Scottsdale has to offer as an ancillary benefit to obtaining advanced treatment for lung disease in Scottsdale. Patient coordinators not only book the stem cell treatments, but they also coordinate hotel accommodations and arrange shuttle services to and from the airport. The patients itinerary is completely taken care of by the Lung Institute and their hotel stay and shuttle services are complimentary for all out-of-town patients.
The clinics opening will be celebrated with a ribbon cutting ceremony held at the new facility. The medical staff, Lung Institute corporate team, community representatives and members of the Scottsdale Chamber of Commerce will be present at the event.
With Scottsdale being a medical hub for new technology, there are unlimited resources in this community. Says Lynne Flaherty, Executive Vice President of the Lung Institute, Additionally, our patients will really enjoy all of the attractions the Scottsdale area has to offer.
Join us for the official ribbon cutting ceremony for the Lung Institute:
When: Monday, February 9, 2015, at 5:00 p.m. Where: Lung Institute, 8377 East Hartford Drive, Suite 120, Scottsdale, AZ 85255 About the Lung Institute At the Lung Institute, we are changing the lives of hundreds of people across the nation through the innovative technology of regenerative medicine. We are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our physicians, through their designated practices, have gained worldwide recognition for the successful application of revolutionary minimally invasive stem cell therapies. With over a century of combined medical experience, our doctors have established a patient experience designed with the highest concern for patient safety and quality of care. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (855)469-5864
See the original post here:
Lung Institute to Celebrate New Expansion with Ribbon Cutting Ceremony
Stem cell research has presented the nation with one of the most divisive ethical issues of the modern age. Aside from the biological implications of stem cell research, many question the morality of issues involving embryos, cloning, and genetic engineering, to identify a few.
While the debate is relatively new, it is rapidly becoming one of the most controversial ethical issues of today. As with most technological advances, the key question is not whether progress is right or wrong, but rather will society use the new power responsibly.
To provide some scientific background on the issue, a stem cell is a cell that has the potential to develop into a number of different types of cells in the body. First discovered in the early 1900s, stem cells were identified and named when researchers realized that various types of blood cells all originated from a particular stem cell (UKSCF, 2007).
When a stem cell divides, each new cell has the potential to either remain the same or become another type of cell in the body with a more specialized function, such as a brain cell, red blood cell, or muscle cell (U.S. Dept. of Health, 2009). For this reason, stem cells are expected to be able to effectively treat a wide variety of diseases and ailments, including spinal cord injury, diabetes, heart disease, blood disorders, and Parkinsons Disease.
Another potential function of stem cells is the ability to create cells, tissue, and even synthetic blood that can be used in medical therapies (AGI News, 2009), thus closing the gap between the high demand for donated organs and tissues and the limited supply currently available for patients in need.
There are two types of stem cells with which scientists can work: adult and embryonic.
Most of the controversy surrounding stem cell research involves embryonic stem cells because they are derived from fertilized embryos, which are subsequently destroyed in the research process.
The embryos used for research, however, are not derived from eggs fertilized in a womans body; rather they are fertilized in vitro in a fertilization clinic and donated for research purposes with informed consent of the donor (Newman, 2009). If they are not used to contribute to the medical community, these embryos will be kept deep frozen in a clinic or discarded altogether. It is for this reason that many supporters of stem cell research argue that the process cannot be accurately compared to destroying human life if the embryos ultimate fate was going to be disposal from the onset of the procedure. It is also not clear as to whether or not the biological fetus is a person and has rights (Garrett, Baille, & Garrett, 2001).
An adult (or somatic) stem cell, on the other hand, is an undifferentiated cell found among differentiated cells in an organ or tissue that has the ability to renew itself, as well as differentiate into a specialized cell type. By their nature, adult stem cells are not as controversial because they can be derived from an individual who may require the therapy by extracting them from the bone marrow or skin cells (National Institues of Health, 2009).
Stem cells, however, do not come only from embryos, bone marrow, and skin. A popular service called cord blood banking is now offered to the families of newborn infants who want to preserve a childs stem cells after birth so that they may be accessed later should stem cell therapy ever become necessary. The cells derived from the babys umbilical cord can also be used to treat blood relatives. If a family decides not to store these cells by having them frozen after birth, then the genetically unique cord blood stem cells are discarded (Cord Blood Registry, 2009).
Visit link:
Stem Cell History | The Stem Cell Research Controversy
Hilary Wong
Tuesday, February 03, 2015
The preeminent Karolinska Institutet will set up its first Asian research center in Hong Kong, which gets a boost in its quest to become a world-class science hub.
Local businessman Lau Ming-wai donated US$50 million (HK$390 million) to set up the Ming Wai Lau Centre for Regenerative Medicine.
The Swedish-Hong Kong center will focus on spinal injuries, a cure for Parkinson's disease, myocardial infarction and stem-cell liver transplant.
Anders Hamsten, vice chancellor of the Stockholm- based institute, said these are extremely critical diseases and groundbreaking research areas.
Karolinska's Nobel Assembly chooses the Nobel laureates in medicine or physiology each year.
The center will recruit 30 scientists through a global recruitment drive, with some of them coming from the institute.
The center's site will be decided in one to two months, with the Science Park one of the sites being considered.
It is expected to be up and running in six months,
Continue reading here:
Top Swedish center boosts science-hub vision of SAR
Contact Information
Available for logged-in reporters only
Newswise The governing board of the California Institute for Regenerative Medicine (CIRM) has awarded two University of California, San Diego researchers almost $3 million in combined funding to pursue new technologies intended to accelerate advances moving stem cell therapies out of the lab and into the clinic.
The funding was part of almost $30 million in new Tools and Technologies awards announced at CIRMs monthly meeting in San Francisco.
Sometimes even the most promising therapy can be derailed by a tiny problem, said Jonathan Thomas, JD, PhD, chair of the CIRM Board. These awards are designed to help find ways to overcome those problems, to bridge the gaps in our knowledge and ensure that the best research is able to keep progressing and move out of the lab and into clinical trials in patients.
Shaochen Chen, PhD, professor in the Department of Nanoengineering in the Jacobs School of Engineering and a member of the Institute of Engineering in Medicine at UC San Diego, received a $1.3 million in CIRM funding for development of 3D bioprinting techniques using human embryonic stem cell-derived heart muscle cells to create new cardiac tissue.
Millions of Americans suffer from cardiovascular disease, specifically congestive heart failure in which a heart valve ceases to work properly. Current treatment often calls for a valve transplant, but donor availability does not meet need.
Chen and colleagues are exploring the possibility of engineering healthy cardiac tissues bioprinted from heart muscle cells, called cardiomyocytes, created from human embryonic stem cells. These tissues could then be implanted in a damaged heart, restoring function.
Shyni Varghese, PhD, associate professor in the Department of Bioengineering at the Jacobs School of Engineering and director of the Bio-Inspired Materials and Stem Cell Engineering Laboratory, received a $1.4 CIRM grant to improve in vivo function of transplanted stem cells.
Vargheses lab focuses upon the complex interactions of cells with their surrounding microenvironment, and how the conditions necessary to promote normal, healthy survival and growth occur.
See more here:
Two UC San Diego Scientists Receive Stem Cell Technology Grants